Gordon Binder
Page Module:Infobox/styles.css has no content.
Gordon M. Binder | |
|---|---|
| Born | Script error: No such module "person date". |
| Died | Script error: No such module "person date". |
| Education | Purdue University (B.S.E.E) Harvard Business School (M.B.A) |
| OccupationTemplate:Pluralize from text | Page Template:Hlist/styles.css has no content.
|
| EmployerTemplate:Pluralize from text | Template:Pluralize from text |
| OrganizationTemplate:Pluralize from text | Template:Pluralize from text |
| AgentTemplate:Pluralize from text | Template:Pluralize from text |
| Notable creditTemplate:Pluralize from text | Template:Pluralize from text |
| LabelTemplate:Pluralize from text | Template:Pluralize from text |
| OpponentTemplate:Pluralize from text | Template:Pluralize from text |
Criminal chargeTemplate:Pluralize from text | Template:Pluralize from text |
| SpouseTemplate:Pluralize from text | Template:Pluralize from text |
| PartnerTemplate:Pluralize from text | Template:Pluralize from text |
| Template:Pluralize from text | |
Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".
Gordon M. Binder (born 1935) is an American businessman.[1][2][3]
Early life and education
Gordon Binder was born in Missouri.[2] He graduated from Purdue University with a Bachelor of Science in Electrical Engineering and received an M.B.A. from the Harvard Business School as a Baker Scholar.[1][2]
Career
Binder worked in managing position at Litton Industries and the Ford Motor Company.[1][3] He served as Chief Financial Officer at the System Development Corporation.[1][3] In 1982, he joined Amgen as CFO.[1] From 1988 to 2000, he served as its CEO.[1][3][4]
He is the Founder and Managing Director of Coastview Capital, a private investment firm.[1][3][5] He also serves as Chairman of SRU Biosystems.[6] He sits on the Boards of Directors of Acadia Pharmaceuticals, Cellular Genomics, PhRMA and the Biotechnology Industry Organization.[1][3] along with Henri Termeer.[7]
He is a member of the Board of Trustees of the Massachusetts Institute of Technology, the California Institute of Technology and the American Enterprise Institute.[1][3][8][9] He was elected a Fellow of the American Academy of Arts and Sciences in 2001.[10]
Bibliography
- Science lessons: What the Business of Biotech Taught Me About Management (with Philip Bashe, Harvard Business Review Press, 2008)
References
Page Template:Reflist/styles.css has no content.
- ^ a b c d e f g h i Page Module:Citation/CS1/styles.css has no content."Gordon M. Binder", Bloomberg Businessweek, nd, archived from the original on June 5, 2013
- ^ a b c Harvard Business School
- ^ a b c d e f g Page Module:Citation/CS1/styles.css has no content."Biography", Milken Institute, nd, archived from the original on 2013-06-19
- ^ Lawrence M. Fisher, BUSINESS PEOPLE; Amgen Officer Shifts Surprise to Analysts, The New York Times, October 27, 1988
- ^ Bloomberg Businessweek: Coastview Capital
- ^ A Sharper Nose for Danger, Bloomberg BusinessWeek, May 24, 2004
- ^ Page Module:Citation/CS1/styles.css has no content.Terrapinn Holdings Ltd (2015). Mr Henri Termeer: Chief Executive Officer, Former Genzyme. Orphan Drug Congress. Retrieved 27 September 2015.
- ^ The MIT Corporation
- ^ Page Module:Citation/CS1/styles.css has no content."American Enterprise Institute Board of Trustees". Archived from the original on 2007-10-02. Retrieved 2007-10-01.
- ^ Page Module:Citation/CS1/styles.css has no content."Book of Members, 1780–2010: Chapter B" (PDF). American Academy of Arts and Sciences. Retrieved July 20, 2011.
Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.
